ATAI Company Profile and Key Details

ATAI has shown mixed momentum, gaining 2.39% over the past week and -40.31% over the past quarter, though year-to-date performance is down -5.87%. Short-term trend indicators are mixed aligned (SMA20 12.72%, SMA50 10.61%, SMA200 11.57%). The stock’s 14-day RSI is 61.42 (firm momentum), while the ATR of 0.28 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -35.7% below its high and over 277.39% above its low. Average 10-day trading volume of 4.37 million shares is slightly above the 3-month average of 3.65 million, indicating heightened recent market interest.

Atai Beckley N.V has 363.21 million shares outstanding. The public float is 301.30 million shares, elevated short interest at 5.03% of float. This equals 15.48 million shares. The short ratio is 3.91 days. Institutional investors hold 30.17% of the float. Insiders own 6.67%. Apeiron Investment Group Ltd. holds 51.05 million shares, ATAI Life Sciences N.V. has 12.00 million shares and Auerbach Michael has 5.56 million shares.

Atai Beckley N.V last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.06. This means the shares are trading below this model’s fair value.

Atai Beckley N.V generated EPS of $nan over the past year. Five-year average earnings growth is 18.62%. Wall Street analysts project EPS growth of 19.84% annually over the next five years. The latest quarter delivered EPS of -$0.28. The next quarter is forecast at -$0.10. Next year's EPS is expected at -$131.78. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 9 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $16.00 to $10.00. The high target offers 268.66% upside. The low target suggests 130.41% downside. The mean target is $13.00. This offers 199.54% upside. Atai Beckley N.V earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 12, 2025, missed forecasts by 133.89%. The prior quarter beat by 16.67%. Over the last six quarters, Apple has recorded several small beats. These include 111.76% in August 13, 2024.

Atai Beckley N.V (NASDAQ:ATAI) closed at $4.34 USD, losing -$0.03 (-0.69%) from the previous close of $4.37. The stock is currently mid-range between its 52-week high and low $1.15 and $6.75. With a market capitalization of about $818.63 million, Atai Beckley N.V is classified as a small-cap and shows higher-than-market volatility (beta ~1.61). Key stats such as the average daily volume over the past year has been around 3.68 million shares, in line with its 52-week average. Headquartered in Amstelveen, None, Atai Beckley N.V operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Srinivas G. Rao, the company employs approximately 54 people and listed since June 18, 2021. Atai Beckley NV is a clinical-stage biopharmaceutical company.

Atai Beckley N.V trades at a P/E ratio of -6.08, slightly below the S&P 500 average, with a price-to-sales ratio of 269.43 and a price-to-book ratio of 5.87 trading at moderately above to book value. The P/FCF stands at -9.0, also below market averages.

Our AI price prediction model suggests that Atai Beckley N.V stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.23%, with price expected at $4.35 by March 11, 2026, within a range of $4.17 to $4.53 3-Month Outlook: Projected rise of 69.59%, reaching $7.36 by May 25, 2026, with a range of $6.94 to $7.87. 1-Year Outlook: Projected gain of 435.02%, with price at $23.22 by February 25, 2027, within a range of $25.10 to $27.62.

Atai Beckley N.V (NASDAQ:ATAI) shares are flat -5.87% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Atai Beckley N.V trading at a premium to the broader market with a P/E of -6.08. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $15.94, suggesting 267.28% upside. Our AI forecast model points to short-term strength (0.23% over two weeks), a medium-term rise (69.59% over three months), and a longer-term gain (435.02% over one year), with expected trading ranges indicating moderate volatility.